Interactions of copper with glycated proteins: Possible involvement in the etiology of diabetic neuropathy

被引:57
作者
Eaton, JW
Qian, MW
机构
[1] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Med, Louisville, KY 40202 USA
关键词
endothelium-derived relaxing factor; diabetic neuropathy; copper; nitrosothiol; nitrix oxide; glycation; glycochelates;
D O I
10.1023/A:1015988817587
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Humans and animals with diabetes frequently develop peripheral vascular dysfunction and peripheral neuropathies. There is accumulating evidence that impaired peripheral nerve function may derive from diminished endoneural blood flow. The decrements in nerve blood flow may, in turn, be due to diminished endothelium-dependent vasodilation. Although a number of possible causes of this defective vasodilation have been suggested, none has been definitely proven. Regardless of the precise cause, the impaired vasodilatory activity may reflect diminished availability of endothelium-derived relaxing factor (EDRF), variously thought to be nitric oxide or thiol adducts of nitric oxide. Other investigators have reported that administration of transition metal chelators to diabetic rats corrects EDRF-mediated arterial relaxation and restores both neural blood flow and nerve conduction velocity, suggesting the involvement of transition metals. Our investigations center about the hypothesis that glycated proteins bind transition metals such as copper and iron, and that such 'glycochelates' accumulate within the vasculature in diabetes and catalytically inactivate EDRF. In partial support of this hypothesis: (1) Glycated albumin binds 3-fold greater amounts of both copper and iron. (2) Copper bound to glycated albumin remains redox active (e.g. capable of supporting the oxidation of ascorbic acid). (3) Copper and copper-containing glycochelates cause the rapid decomposition of one putative form of EDRF, nitrosocysteine. (4) The amount of exchangeable (i.e. chelatable) copper in the plasma of diabetic rats is approximately twice that in normal rat plasma. (5) Similarly, tail tendons of diabetic animals have about twice as much bound copper as do tendons of normal rats. (6) Implants bearing adsorbed glycated albumin placed in the peritonea of normal mice for 48 h accumulate 5 times as much bound copper as do implants coated with control albumin. Overall, these observations support - but do not conclusively prove - the hypothesis that transition metals such as copper, bound to glycated proteins, may blunt normal EDRF-dependent relaxation of diabetic arteries and provide a rationale for the use of transition metal chelators in the therapy of diabetic vasculopathy and neuropathy.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 35 条
[1]   A QUANTITATIVE TEST FOR COPPER USING BICINCHONINIC ACID [J].
BRENNER, AJ ;
HARRIS, ED .
ANALYTICAL BIOCHEMISTRY, 1995, 226 (01) :80-84
[2]   ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[3]   NEUROVASCULAR DYSFUNCTION IN DIABETIC RATS - POTENTIAL CONTRIBUTION OF AUTOXIDATION AND FREE-RADICALS EXAMINED USING TRANSITION-METAL CHELATING-AGENTS [J].
CAMERON, NE ;
COTTER, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1159-1163
[4]   Effects of an extracellular metal chelator on neurovascular function in diabetic rats [J].
Cameron, NE ;
Cotter, MA .
DIABETOLOGIA, 2001, 44 (05) :621-628
[5]   Convenient colorimetric and fluorometric assays for S-nitrosothiols [J].
Cook, JA ;
Kim, SY ;
Teague, D ;
Krishna, MC ;
Pacelli, R ;
Mitchell, JB ;
Vodovotz, Y ;
Nims, RW ;
Christodoulou, D ;
Miles, AM ;
Grisham, MB ;
Wink, DA .
ANALYTICAL BIOCHEMISTRY, 1996, 238 (02) :150-158
[6]  
Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54
[7]  
Cosentino F, 1997, CIRCULATION, V96, P25
[8]   The chemistry and tumoricidal activity of nitric oxide hydrogen peroxide and the implications to cell resistance susceptibility [J].
FariasEisner, R ;
Chaudhuri, G ;
Aeberhard, E ;
Fukuto, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6144-6151
[9]  
Honing MLH, 1998, DIABETES METAB REV, V14, P241, DOI 10.1002/(SICI)1099-0895(1998090)14:3<241::AID-DMR216>3.0.CO
[10]  
2-R